СПОСОБ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ, СОЧЕТАННОЙ С ЭРОЗИВНО-ЯЗВЕННЫМИ ПОРАЖЕНИЯМИ ГАСТРОДУОДЕНАЛЬНОЙ ЗОНЫ

摘要

FIELD: medicine, pulmonology, gastroenterology. ^ SUBSTANCE: in 10 d after the onset of therapeutic course at applying basis therapy one should introduce antidepressant - fluvoxamine maleate for patients with observed anxious-depressive disorders at the dosage of 50 mg daily in evening period for 8 wk. The present innovation enables to decrease the degree of symptoms of the above-mentioned disease at the background of decreased number of relapses of bronchial asthma, in case of resistance to conventional therapy, diseases of gastroduodenal area and normalization of psychic status in patients, among them. ^ EFFECT: higher efficiency of therapy. ^ 1 ex